HomeNDC LookupIngredientsNaproxen › 70518-4750-00
Naproxen 500 mg Tablet, 30-count — NDC 70518-4750-00 package photo

Naproxen 500 mg Tablet, 30-count

by REMEDYREPACK INC. · 30 TABLET in 1 BLISTER PACK (70518-4750-0)
NDC 70518-4750-00
🏷️ FDA NDC (as labeled) 70518-4750-0 billing pads the package segment with a zero
Rx only Generic On market Non-controlled
🗂️ Data synced Sep 17, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
⚠️
Other active recalls for Naproxen (different manufacturers) — 1 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Apr 20, 2026 — Chemical contamination; presence of lead and lithium above specification (Acella Pharmaceuticals, LLC) · FDA recall D-0523-2026
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

🆔 Identity & classification

FDA NDC (as labeled) 70518-4750-0
Product NDC 70518-4750
11-digit billing NDC 70518475000
Application # ANDA200429
SPL Set ID ee0a80d6-669d-4f1c-b7bb-1ca8f1982a4b
Established class (EPC) Anti-Inflammatory Agents; Nonsteroidal Anti-inflammatory Drug
Mechanism of action Cyclooxygenase Inhibitors
Chemical class Non-Steroidal
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2026-09-11
Route ORAL
Dosage form TABLET
Substance NAPROXEN
TE code (Orange Book) AB · RLD · RS
Why two NDCs? The FDA registers this code as 70518-4750-0 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70518-4750-00. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏭 Manufacturer & labeler

LabelerREMEDYREPACK INC.
Application holderAUROBINDO PHARMA LTD
FDA applicationANDA200429 (ANDA)
Labeler code70518
First marketedSep 2026
Product typeHuman Prescription Drug
Portfolio1,511 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

📗 Our plain-language guide HelloPharmacist
  • They're very similar — naproxen sodium is just the salt form of naproxen, and it dissolves in water more quickly. That means your body absorbs naproxen sodium a bit faster, so it t...
  • What's the difference between naproxen and naproxen sodium — are they the same thing?
  • You can take it either way, but taking it with food, milk, or a full glass of water is a good idea because it helps protect your stomach. Naproxen can irritate the lining of your s...
  • Can I take naproxen on an empty stomach, or do I need to eat first?
📖 Read our full Naproxen guide →
1
Nutrient depletion considerations

Naproxen may be associated with lower levels of 1 nutrient — worth a chat with your pharmacist, not a cause for alarm.

An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

💊 What it looks like

Color yellow
ShapeCapsule
ImprintT;20
Size19 mm
ScoringScored — splits in 2
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII EX438O2MRT
    Ferric oxide yellow is a naturally occurring iron compound used as a colorant in medications. It gives tablets, capsules, and other forms a yellow or golden hue for identification and appearance.
  • UNII EWQ57Q8I5X
    Lactose monohydrate is a natural sugar derived from milk. It serves as a filler and binder in tablets and capsules, helping create the proper size, texture, and consistency of the medicine.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII U725QWY32X
    Povidone K30 is a synthetic polymer made from petroleum. It acts as a binder to hold tablet ingredients together and as a disintegrant to help the tablet break apart in the stomach so the medicine can be absorbed.
  • UNII 5856J3G2A2
    A starch-based powder made from potatoes and processed with sodium. It acts as a disintegrant, helping the tablet or capsule break apart quickly in the stomach so the medicine can be absorbed.
  • UNII O8232NY3SJ
    A plant-based carbohydrate derived from corn kernels. It acts as a filler to add bulk, a binder to hold ingredients together, and a disintegrant to help the tablet break apart in your stomach for absorption.

6 inactive ingredients listed in the exact product block matched to this NDC.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMedingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Naproxen 500 mg 49483-0618-01 TIME 100 tablets $0.058 AB Availability likely
Naproxen 500 mg 76282-0342-01 Exelan 100 tablets $0.058 Availability likely
Naproxen 500 mg 65862-0522-01 Aurobindo 100 tablets $0.058 AB Availability likely
Naproxen 500 mg 50228-0436-01 ScieGen 100 tablets $0.058 AB Availability likely
Naproxen 500 mg 70010-0139-01 Granules 100 tablets $0.058 AB Availability likely
Naproxen 500 mg 65162-0190-10 Amneal 100 tablets $0.058 AB Availability likely
Naproxen 500 mg 60687-0491-01 American 100 tablets $0.058 AB Availability likely
Naproxen 500 mg 68462-0190-01 Glenmark 100 tablets $0.058 AB Availability likely
Naproxen 500 mg 42494-0454-10 Cameron 100 tablets $1.864 AB Availability likely
Naproxen 500 mg 00615-8094-39 NCS 30 tablets AB FDA listed
Naproxen 500 mg 43353-0211-53 Aphena 60 tablets FDA listed
Naproxen 500 mg 63187-0028-10 Proficient 10 tablets AB FDA listed
Naproxen 500 mg 63187-0455-20 Proficient 20 tablets AB FDA listed
Naproxen 500 mg 71205-0597-10 Proficient 10 tablets AB FDA listed
Naproxen 500 mg 71610-0436-53 Aphena 60 tablets AB FDA listed
Naproxen 500 mg 71610-0489-53 Aphena 60 tablets AB FDA listed
Naproxen 500 mg 71610-0597-53 Aphena 60 tablets AB FDA listed
Naproxen 500 mg 76420-0042-01 Asclemed 1 tablet AB FDA listed
Naproxen 500 mg 50090-6666-00 A-S 15 tablets AB FDA listed
Naproxen 500 mg 50090-6667-01 A-S 90 tablets AB FDA listed
Naproxen 500 mg 50090-6762-00 A-S 20 tablets AB FDA listed
Naproxen 500 mg 50090-6980-00 A-S 90 tablets AB FDA listed
Naproxen 500 mg 63629-8514-01 Bryant 500 tablets AB FDA listed
Naproxen 500 mg 63629-8515-01 Bryant 100 tablets AB FDA listed
naproxen 500 mg 69097-0855-07 Cipla 100 tablets FDA listed
Naproxen 500 mg 50090-5645-00 A-S 15 tablets AB FDA listed
Naproxen 500 mg 50090-7676-00 A-S 90 tablets AB FDA listed
Naproxen 500 mg 80425-0378-01 Advanced 30 tablets AB FDA listed
Naproxen 500 mg 43063-0920-04 PD-Rx 4 tablets AB FDA listed
Naproxen 500 mg 68788-7090-01 Preferred 100 tablets AB FDA listed
Naproxen 500 mg 72789-0541-14 PD-Rx 14 tablets AB FDA listed
Naproxen 500 mg 85509-1436-03 PHOENIX 30 tablets AB FDA listed
Naproxen 500 mg 42708-0043-20 QPharma, 20 tablets AB FDA listed
Naproxen 500 mg 50090-7198-00 A-S 90 tablets AB FDA listed
Naproxen 500 mg 51655-0457-20 Northwind 20 tablets AB FDA listed
Naproxen 500 mg 51655-0743-20 Northwind 20 tablets AB FDA listed
Naproxen 500 mg 63629-5863-01 Bryant 60 tablets AB FDA listed
Naproxen 500 mg 66267-0153-10 NuCare 10 tablets AB FDA listed
Naproxen 500 mg 68071-2396-04 NuCare 4 tablets AB FDA listed
Naproxen 500 mg 68071-4006-01 NuCare 10 tablets AB FDA listed
Naproxen 500 mg 51655-0621-20 Northwind 20 tablets AB FDA listed
Naproxen 500 mg 67046-1553-03 Coupler 30 tablets AB FDA listed
Naproxen 500 mg 71335-2777-00 Bryant 28 tablets AB FDA listed
Naproxen 500 mg 72189-0136-14 DIRECT 14 tablets AB FDA listed
Naproxen 500 mg 50090-0481-00 A-S 15 tablets AB FDA listed
Naproxen 500 mg 60760-0564-14 St. 14 tablets AB FDA listed
Naproxen 500 mg 67296-2235-05 Redpharm 30 tablets AB FDA listed
Naproxen 500 mg 68071-4381-02 NuCare 20 tablets AB FDA listed
Naproxen 500 mg 68788-8602-01 Preferred 100 tablets AB FDA listed
Naproxen 500 mg 72789-0321-04 PD-Rx 4 tablets AB FDA listed
Naproxen 500 mg 77771-0436-01 Radha 100 tablets AB FDA listed
Naproxen 500 mg 50090-5646-01 A-S 90 tablets AB FDA listed
Naproxen 500 mg 50090-5649-00 A-S 20 tablets AB FDA listed
Naproxen 500 mg 71335-0345-00 Bryant 28 tablets AB FDA listed
Naproxen 500 mg 72162-2276-01 Bryant 100 tablets AB FDA listed
Naproxen 500 mg 80425-0049-01 Advanced 60 tablets AB FDA listed
Naproxen 500 mg 80425-0051-01 Advanced 60 tablets AB FDA listed
Naproxen 500 mg 85766-0107-00 Sportpharm 1000 tablets AB FDA listed
Naproxen 500 mg 53746-0190-01 Amneal 100 tablets AB FDA listed
Naproxen 500 mg 76420-0264-01 Asclemed 1 tablet AB FDA listed
Naproxen 500 mg 50090-0482-01 A-S 90 tablets AB FDA listed
Naproxen 500 mg 51655-0363-26 Northwind 90 tablets AB FDA listed
Naproxen 500 mg 66267-0807-04 NuCare 4 tablets AB FDA listed
Naproxen 500 mg 70518-3822-00 REMEDYREPACK 30 tablets AB FDA listed
Naproxen 500 mg 71335-2485-00 Bryant 28 tablets AB FDA listed
Naproxen 500 mg 80425-0050-01 Advanced 60 tablets AB FDA listed
Naproxen 500 mg 50090-0483-00 A-S 20 tablets AB FDA listed
Naproxen 500 mg 55700-0888-20 Quality 20 tablets AB Discontinued
Naproxen 500 mg 68788-8797-01 Preferred 100 tablets AB FDA listed
Naproxen 500 mg 82461-0711-60 Medcore 60 tablets AB FDA listed
Naproxen 500 mg 83209-0190-14 Boswell 14 tablets AB FDA listed
Naproxen 500 mg 25000-0140-03 MARKSANS 30 tablets AB FDA listed
Naproxen 500 mg 42708-0140-20 QPharma 20 tablets AB FDA listed
Naproxen 500 mg 67046-0501-03 Coupler 30 tablets AB FDA listed
Naproxen 500 mg 70518-4439-00 REMEDYREPACK 12 tablets AB FDA listed
Naproxen 500 mg 87441-0060-01 Unit 30 tablets AB FDA listed
Naproxen 500 mg 85534-0024-00 HAWAII 30 tablets AB FDA listed
Naproxen 500 mg 70518-1516-00 REMEDYREPACK 30 tablets AB Discontinued
Naproxen 500 mg 67046-0784-03 Coupler 30 tablets AB FDA listed
Naproxen 500 mgthis 70518-4750-00 REMEDYREPACK 30 tablets AB FDA listed
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2026
On the market since
Sep 2026
📍
2026
Currently FDA-listed
listed with the FDA
🔓
·
Generic on the market
this product is a generic
This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

📊 Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Naproxen — the program that covers self-administered drugs. 17 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Naproxen. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$5.99M
Claims incl. refills
655K
Beneficiaries
478.5K
Spend / beneficiary
$12.52
Spend / claim
$9.15
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Naproxen — the ingredient across all brands.

Top reported reactions

Pain13,409
Fatigue13,047
Nausea12,185
Arthralgia11,086
Headache10,504
Diarrhoea9,841
Dizziness9,098

Age at onset

Neonate147
Infant81
Child444
Adolescent528
Adult19,141
Elderly11,983

Reporter sex

165,062 reports
Male · 32%
Female · 67%
Unknown · 0%

Serious outcomes

Hospitalization41,131
Disabling9,239
Life-threatening9,236
Reports over time (by year) — tap or hover for the count & year
2020 2022 2024 2026 12,169 3,619
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
70518-4750-00 You're viewing this 30 TABLET in 1 BLISTER PACK (70518-4750-0) 2026-09-11 Active

🧭 About this NDC listing & data coverage

Finished prescription product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data ✓ Available
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 70518-4750-0, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 70518-4750-00, written without dashes as 70518475000. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 70518-4750-00, the first segment (70518) is the labeler code FDA assigned to REMEDYREPACK INC.; the middle segment (4750) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (00) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by REMEDYREPACK INC.. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
REMEDYREPACK INC. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label 19 words

No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.